Salacia chinensis stem extract and its thiosugar sulfonium constituent, neokotalanol, improves HbA1c levels in ob/ob mice.


Journal

Journal of natural medicines
ISSN: 1861-0293
Titre abrégé: J Nat Med
Pays: Japan
ID NLM: 101518405

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 27 02 2019
accepted: 10 04 2019
pubmed: 28 4 2019
medline: 14 8 2019
entrez: 28 4 2019
Statut: ppublish

Résumé

The antidiabetic effects of a hot water extract of the stems of Salacia chinensis (SCE) were evaluated in vivo in ob/ob mice (genetically obese hyperglycemic mice). Administration of dietary feed containing 0.20 and 0.50% of SCE for 23 days to ob/ob mice significantly suppressed the elevation of both blood glucose and HbA1c levels, without significantly changing body weight and food intake. To characterize the antidiabetic effects of the thiosugar sulfonium constituent neokotalanol (1), which has potent α-glucosidase inhibitory activity, we performed a similar in vivo study. HbA1c levels were significantly suppressed in ob/ob mice after the administration of dietary feed containing 0.0003% of neokotalanol (1) for 20 days. These results indicate that SCE and neokotalanol (1) are potential leads for the development of novel antidiabetic agents.

Identifiants

pubmed: 31028661
doi: 10.1007/s11418-019-01311-w
pii: 10.1007/s11418-019-01311-w
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
Glycoside Hydrolase Inhibitors 0
Hypoglycemic Agents 0
Plant Extracts 0
Thiosugars 0
neokotalanol 0

Types de publication

Journal Article

Langues

eng

Pagination

584-588

Subventions

Organisme : MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018
ID : S1411037
Organisme : a Grant-in-aid for Scientific Research (KAKENHI)
ID : 18K06739
Organisme : a Grant-in-aid for Scientific Research (KAKENHI)
ID : 16K08313
Organisme : a Grant-in-aid for Scientific Research (KAKENHI)
ID : 18K06726

Références

Bioorg Med Chem. 2011 Mar 15;19(6):2015-22
pubmed: 21345683
Yakugaku Zasshi. 2008 Jun;128(6):867-80
pubmed: 18520134
Endocrinology. 1980 Sep;107(3):671-6
pubmed: 6249569
J Nat Med. 2011 Jan;65(1):142-8
pubmed: 20981499
Yakugaku Zasshi. 2003 Oct;123(10):871-80
pubmed: 14577333
Bioorg Med Chem. 2002 May;10(5):1547-54
pubmed: 11886816
Biochem Pharmacol. 2010 Jun 1;79(11):1674-83
pubmed: 20144590
Curr Diab Rep. 2016 Feb;16(2):18
pubmed: 26814757
Phytochem Anal. 2014 Nov-Dec;25(6):544-50
pubmed: 24816820
Curr Diabetes Rev. 2014 Mar;10(2):131-45
pubmed: 24809394
Metabolism. 1953 Jan;2(1):9-21
pubmed: 13002079
J Pharm Biomed Anal. 2010 Sep 5;52(5):770-3
pubmed: 20303690
Diabetologia. 2012 May;55(5):1469-81
pubmed: 22095235
ScientificWorldJournal. 2007 May 29;7:666-85
pubmed: 17619751
Biochim Biophys Acta. 2005 Jun 10;1740(3):319-25
pubmed: 15949698
J Diabetes Investig. 2012 Feb 20;3(1):39-40
pubmed: 24843544
Nutrients. 2015 Feb 27;7(3):1480-93
pubmed: 25734563
J Nutr. 2008 Jun;138(6):1192S-8S
pubmed: 18492856

Auteurs

Masakazu Kobayashi (M)

Central R&D Laboratory, Kobayashi Pharmaceutical Co., Ltd., 1-30-3, Toyokawa, Ibaraki, Osaka, 567-0057, Japan. masa-kobayashi@kobayashi.co.jp.

Junji Akaki (J)

Central R&D Laboratory, Kobayashi Pharmaceutical Co., Ltd., 1-30-3, Toyokawa, Ibaraki, Osaka, 567-0057, Japan.
Pharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.

Yasuyo Yamaguchi (Y)

Central R&D Laboratory, Kobayashi Pharmaceutical Co., Ltd., 1-30-3, Toyokawa, Ibaraki, Osaka, 567-0057, Japan.

Hiroo Yamasaki (H)

Central R&D Laboratory, Kobayashi Pharmaceutical Co., Ltd., 1-30-3, Toyokawa, Ibaraki, Osaka, 567-0057, Japan.

Kiyofumi Ninomiya (K)

Pharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.
Antiaging Center, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.

Yutana Pongpiriyadacha (Y)

Faculty of Science and Technology, Rajamangala University of Technology Srivijaya, Thungyai, Nakhon Si Thammarat, 80240, Thailand.

Masayuki Yoshikawa (M)

Pharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.

Osamu Muraoka (O)

Pharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.
Antiaging Center, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.

Toshio Morikawa (T)

Pharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan. morikawa@kindai.ac.jp.
Antiaging Center, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan. morikawa@kindai.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH